Jiangsu TASUN Group Diyi Pharmaceutical

Jiangsu Dasheng Group Diyi Pharmaceutical is a prominent Chinese pharmaceutical manufacturer based in the Lianyungang economic development zone. As a core subsidiary of the Jiangsu Dasheng Group (also known as TASUN Group), the company specializes in the large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms, including tablets, capsules, and granules. Its commercial portfolio is primarily focused on small molecule generics across therapeutic areas such as anti-infectives, cardiovascular health, and metabolic disorders. The company operates multiple GMP-certified facilities and maintains a significant presence in both the domestic Chinese market and international export markets. By leveraging integrated chemical synthesis capabilities, the firm provides cost-effective treatments for common chronic and acute conditions.